Medical Management of Diabetes and Heart Disease - part 6 pdf
Medical Management of Diabetes and Heart Disease - part 6 pdf
... 1988; 66 :580–583.
16. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnor-
malities: the role of insulin resistance and the sympathoadrenal system. N Engl J
Med 19 96; ... diabetes in the world ( 16) . Evidence for an enhanced rate of development
of diabetes is also evident from long-term follow-up of women with PCOS (17).
PCO and Insulin Resist...
Medical Management of Diabetes and Heart Disease - part 1 pps
... NY 100 16
tel: 21 2 -6 9 6- 9 000; fax: 21 2 -6 8 5-4 540
Eastern Hemisphere Distribution
Marcel Dekker AG
Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland
tel: 4 1 -6 1-2 6 1-8 482; fax: 4 1 -6 1-2 6 1-8 8 96
World ... 45: 166 1– 166 9.
23. Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibi-
tor type-1 by insulin and insulin-like...
Medical Management of Diabetes and Heart Disease - part 2 pps
... Report of the expert committee on the diagnosis and classification of diabetes melli-
tus. Diabetes Care 2001; 24(suppl 1):S5–S20.
2. Wingard DL, Barrett-Cannor E. Heart disease and diabetes. In: Diabetes ... secretion and insulin action in non-insulin-dependent diabetes mel-
litus are inherited: Metabolic studies on offspring of diabetic probands. J Clin Invest
1998;...
Medical Management of Diabetes and Heart Disease - part 3 ppt
... Hemmings BA, Ballmer-Hofer K, Thelen M. Constitu-
tive activation of protein kinase B and phosphorylation of p47phox by a membrane-
targeted phosphoinositide 3-kinase. Curr Biol 19 96; 6: 1271–1278.
55. ... of calcium-channel blockade in
older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340:
67 7 68 4.
68 . UK Prospective Diabetes Study Group. Tight b...
Medical Management of Diabetes and Heart Disease - part 4 docx
... evolution and persistence of
thrombosis and the rapidity and extent of lysis of thrombi associated with vascular
damage and its repair, overexpression of PAI-1 is likely to exacerbate both devel-
opment ... concentra-
tion of PAI-1 in blood in normal subjects. Both phenomena, hormonal (hyperin-
sulinemia) and metabolic (hyperglycemia and hypertriglyceridemia) derange-
me...
Medical Management of Diabetes and Heart Disease - part 5 pot
... (IRS-1 and IRS-2), and activation of the phosphoinositol 3′ kinase
(PI-3′-K) pathway. On the other hand, cell growth and differentiation are regu-
lated primarily by the SHC, GRB-2, and the MAP-kinase ... concentration of 1 26 mg/dL and the 2-h OGTT value
of 200 mg/dL and both of these levels correlate well with the appearance of
microvascular complications of diabet...
Medical Management of Diabetes and Heart Disease - part 7 pps
... effect of nisoldipine as compared
with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:
64 5 65 2.
26. Fein F, Scheur J. Heart disease in diabetes mellitus: theory and practice. ... lev-
els of high-density-lipoprotein (HDL) cholesterol, and increased low-density-li-
poprotein (LDL) cholesterol, hypertension, and central obesity with an increased...
Medical Management of Diabetes and Heart Disease - part 9 docx
... PTCA- and CABG-treated patients even in subgroups of
diabetes and three-vessel disease (31). In addition to the randomized trials com-
paring PCI and CABG, three large, single-center registries and ... time of
restenosis, that is 3 to 4 months post-intervention. For long-term follow-up of
268 Peragallo-Dittko
Table 3 Recommendations Regarding Diabetes and Smoking
Assessm...
Medical Management of Diabetes and Heart Disease - part 10 potx
... Department of
Medicine and Professor of Biochemistry at the University of Vermont College
of Medicine and Physician-in-Chief, Fletcher Allen Health Care, Burlington, Ver-
mont. The editor of Medical Management ... diabetes in the
offspring of diabetic parents. Ann Intern Med 1990; 113:909–915.
Index 283
Cardiovascular complications, preva-
lence, 66 67
Cardiovascular...
Từ khóa: